The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Rns out this am,could WE be the partner
PathFlow (R) SARS-CoV-2 Antigen is a professional and home use LFT for the detection of SARS-CoV-2 antigens using non-invasive anterior nasal swab samples to provide a result in approximately 15 minutes. Novacyt has been working with a partner to develop this test, which is able to detect the virus regardless of current known mutations. The Company intends to launch the test as CE-IVD before the end of Q2 2021 and expects it to complement Novacyt's established position in COVID-19 PCR testing. As the market for COVID-19 testing continues to develop, the Directors believe this product could add significant revenues for Novacyt.
Agreed superb RNS for Novacyt, great PR quick respond, hope our CEO will look closely to it and may be one day.
Four kinds of bull**** please stop with the negative comments your so annoying and its obvious your a day trader
Ncyt & GDR both have good RNS' out today.
Come on ODX make it three !
Hold strong here guys its the last week of April next week I have s feeling we will get BIG news.
I didn't see NCYT's lateral flow devices on the PHE list debated yesterday !
Billions of LFTs needed in the UK alone to keep the UK for
lockdown, Government can’t afford that hence the massive push for everyone to be tested wherever they travel or attend... ODX are one of the MEGA MANUFACTURING COVID WARTIME GIANTS for LFTS STARTING IMMINENTLY.
STOCKPILES OF VISITECT PRODUCTS ARE THERE TO SEE
contracts have been awarded
Got to be in it to win it and benefit from the impending rerate multi bag that’s around the corner
Their antigen LFT is in R&D => not ready, in research and development. Just shows the demand is there.
We are almost ready to ship 2m per week, we are way ahead.
"MEGA MANUFACTURING COVID WARTIME GIANTS "
That takes the all time biscuit !
"We are almost ready to ship 2m per week"
I thought we were delivering 2M test a week in April?
If you compare the covid testing industry to the chocolate industry, Omega will be like Cadbury’s!!!
and you know the UK can’t keep themselves from buying Cadbury’s daily!!!!
"Omega will be like Cadbury’s!!!"
Chocolate Teapots spring to mind !
I did feel that way but I believe he is too busy with Commercial launch of antigen test and TT completion as he knows he's up against it he only has a week and knows he needs to deliver.
And Cadburys was sold to the Americans!
"knows he needs to deliver"
I'm glad i am not relying on him to deliver my morning newspaper, if i was, i'd just be reading about something new called Covid coming out of china.
The TT & Sovereign test RNS will come as will all the other announcements relating to Visitect. I’m sure CK & all his hundreds of new employees & all their new Covid wartime machinery aren’t sat idle waiting.
I can just imagine them all with their ear defenders on, I reckon them machines will be deafening in overdrive.
I’m sure the engineers will make sure theyre kept in good order for them to run at full capacity!!!
Listening to comments on this board is as useful as a chocolate teapot )
Everyone has a opinion but literally no one has any facts haha.
I see no RNS today so im off. No reason to listen to girls fighting in a playground.
sentinel85uk
"Listening to comments on this board is as useful as a chocolate teapot )"
Or an ejector seat in a helicopter.
FFB - Why you on here! You can sell if indeed you are invested. But you are clearly very unhappy. SO you are convinced this is a rubbish stock SO LEAVE! Bye :).
I have held Odx for about a year and there is so much view on this bb that I rarely feel need to add. However I must say I am disappointed in the comms now. We know from tweets that we have 200 employees and they are busy. But that’s it. TT is overdue by our guesses timeline and personally I would like an update on both of these.
I still feel there could be plenty of upside given the macro scenario and hence still here but I will continue to derisk at first targets as I feel they are abusing my trust with this continual silence.
I have invested for 20 years and I have never had less idea of what the underlying status and progress of a company might be. Don’t react by calling me a deramper, but rather go through your own investments past and present - have you ever had less idea as to what is going on?
In summary greed keeps me holding on but I am beginning to consider how much it would hurt to take the drop to firmer ground. Prob end may will see me leave if no further progress.
If your so upset , depressed and anxious about colin and the whole ODX company , then why are you here? why are you telling us all your depressing opinions?
haha i dont understand half the comments on here.
Buy it because you see growth in the future.
Sell it if you see no growth in the future.
Absolutely pointless coming on here and crying to us all about how upset you are. We aint your mother to comfort you. Man up and make a decision but guess what? Dont fuking tell us cos we really dont give 2 fuks hahaha. Boring ass comments . Back to normal life for me . peace out
Nelsonthedog i agree with your sentiments ... i also hold Genedrive and Hemogenyx and find their updates are awful as well and therefore every relies on Tweets which are generally from rampers or derampers. When something then doesnt happen the next day, the price goes down. This has been happening with ODX as well for a long time and I agree that all it needs is an update every month to allay the negativity and keep the investment into ODX flowing
Fourfigures
I am not disgusted - that’s a strong emotion. I am disappointed - a more reflective reflection as befits a passive investor. The bod hasn’t done anything to invoke extreme emotion and there isn’t a problem we know of to be disgusted by. I am just reflecting that I genuinely have no idea what they are doing. That isn’t the normal state of play as an investor.
Please don’t try and superheat my comments to continue the undertone of urgency that often prevails on this board - it isn’t helpful in gaining others views, which is after all what we hope for from a bb.
Gla
NtD
Nelson, correct me if I am wrong but isn't TT a given where CE is granted, which is the case here I believe.
I suspect newsflow is impacted by the Government not yet apparently having settled on LF Test of choice, or has it? Certainly 200 plus employees are doing something.
The dam will burst and we will have torrents of news but I agree hurry up ODX where you can.
So frustrating currently.